Trials / Completed
CompletedNCT02722850
Web-based Study for Cancer Survivors
A Lifestyle Intervention Via Email (ALIVE) for Cancer Survivors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 258 (actual)
- Sponsor
- University of North Texas Health Science Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In this parallel group study, participants were randomized to either 1 of 3 conditions (a) fruit and vegetable consumption, (b) dietary fat and added sugars, or (c) physical activity.
Detailed description
In this study, the investigators will evaluate the feasibility and preliminary results of a 3-month web-based lifestyle intervention 500 female cancer survivors. Specific aim 1: to determine the rates of recruitment, retention, attendance, satisfaction, adverse events, and barriers to participation in the proposed intervention. Specific aim 2: to determine whether a home-based intervention is associated with greater improvements in mean minutes of moderate to vigorous physical activity, diet quality, body size, constructs of Social Cognitive Theory, and health-related quality of life than participants randomized to a sedentary behavior reduction condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ALIVE | ALIVE is an email-based platform designed to help participants increase their physical activity, increase fruit and vegetable consumption, and decrease their intake of saturated and trans fats and added sugars. This automated system contains content and tailoring that is delivered in the form of emails obtained directly from cancer patients. Additional information they will receive included: tips for achieving those goals, health information, and opportunities for interaction and engagement. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-12-01
- Completion
- 2016-06-01
- First posted
- 2016-03-30
- Last updated
- 2016-12-01
Source: ClinicalTrials.gov record NCT02722850. Inclusion in this directory is not an endorsement.